Literature DB >> 28265327

Neuropathic bladders: Investigation and treatment through their lifetime.

Peter D Metcalfe1.   

Abstract

The child with a neuropathic bladder requires lifelong dedicated care. Just as each patient presents with unique physiology, each phase of their life presents varying challenges. The primary concern for our patients is their renal health, but continence and independence also play significant roles. Most patients can be managed conservatively, but a myriad of surgical options are also available, reinforcing our emphasis on individualized care. Appropriate pre-surgical planning is required to ensure the right patient receives the best operation for his/her wants and needs. Furthermore, the numerous potential complications must be understood and long-term followup and surveillance is required. This review outlines the basic pathophysiology, investigations, and treatments, with a focus on the changing needs throughout their lives.

Entities:  

Year:  2017        PMID: 28265327      PMCID: PMC5332244          DOI: 10.5489/cuaj.4276

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN: 1911-6470            Impact factor:   1.862


  44 in total

Review 1.  Intravesical gentamicin for recurrent urinary tract infection in patients with intermittent bladder catheterisation.

Authors:  C van Nieuwkoop; P L den Exter; H W Elzevier; J den Hartigh; J T van Dissel
Journal:  Int J Antimicrob Agents       Date:  2010-06-26       Impact factor: 5.283

2.  What is the need for additional bladder surgery after bladder augmentation in childhood?

Authors:  P D Metcalfe; M P Cain; M Kaefer; D A Gilley; K K Meldrum; R Misseri; S J King; A J Casale; R C Rink
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

3.  Categorization of bladder dynamics and treatment after fetal myelomeningocele repair: first 50 cases prospectively assessed.

Authors:  Marcela Leal da Cruz; Riberto Liguori; Gilmar Garrone; Bruno Leslie; Sérgio Leite Ottoni; Sérgio Carvalheiro; Antonio Fernandes Moron; Valdemar Ortiz; Antonio Macedo
Journal:  J Urol       Date:  2015-03-25       Impact factor: 7.450

4.  The Malone antegrade continence enema procedure: quality of life and family perspective.

Authors:  Elizabeth B Yerkes; Mark P Cain; Shelly King; Timothy Brei; Martin Kaefer; Anthony J Casale; Richard C Rink
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

5.  Decreased bladder compliance in patients with myelomeningocele treated with radiological observation.

Authors:  A M Kaufman; M L Ritchey; A C Roberts; D C Rudy; E J McGuire
Journal:  J Urol       Date:  1996-12       Impact factor: 7.450

6.  Detrusor hyper-reflexia as a factor in spontaneous perforation of augmentation cystoplasty for neuropathic bladder.

Authors:  P A Anderson; A M Rickwood
Journal:  Br J Urol       Date:  1991-02

7.  A randomized trial of prenatal versus postnatal repair of myelomeningocele.

Authors:  N Scott Adzick; Elizabeth A Thom; Catherine Y Spong; John W Brock; Pamela K Burrows; Mark P Johnson; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Leslie N Sutton; Nalin Gupta; Noel B Tulipan; Mary E D'Alton; Diana L Farmer
Journal:  N Engl J Med       Date:  2011-02-09       Impact factor: 91.245

8.  Intravesical instillation of gentamicin sulfate: in vitro, rat, canine, and human studies.

Authors:  J Wan; M Kozminski; S C Wang; G J Faerber; E J McGuire; D A Bloom; M L Ritchey
Journal:  Urology       Date:  1994-04       Impact factor: 2.649

9.  Factors that influence outcomes of the Mitrofanoff and Malone antegrade continence enema reconstructive procedures in children.

Authors:  Travis Clark; John C Pope; mark C Adams; Nancy Wells; John W Brock
Journal:  J Urol       Date:  2002-10       Impact factor: 7.450

10.  Bladder Function After Fetal Surgery for Myelomeningocele.

Authors:  John W Brock; Michael C Carr; N Scott Adzick; Pamela K Burrows; John C Thomas; Elizabeth A Thom; Lori J Howell; Jody A Farrell; Mary E Dabrowiak; Diana L Farmer; Earl Y Cheng; Bradley P Kropp; Anthony A Caldamone; Dorothy I Bulas; Susan Tolivaisa; Laurence S Baskin
Journal:  Pediatrics       Date:  2015-10       Impact factor: 7.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.